VTAK Earnings — Catheter Precision, Inc. Post-ER Performance | BigEarnings
VTAK — Catheter Precision, Inc.
XASE · Healthcare · Medical Devices
Price$0.88
Market Cap$2.4M
P/E—
52W Range$0.75 – $15.68
Next Earnings2026-08-10
About Catheter Precision, Inc.
Catheter Precision Inc is engaged in the design, manufacture, and sale of medical technologies focused in the field of cardiac electrophysiology, or EP. The company's two primary products include the VIVO System and LockeT. The VIVO System, which is an acronym for View into Ventricular Onset System(VIVO or VIVO System), is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its newest product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure.
🤖 AI Earnings Analysis
Catheter Precision raised **$3.5M through Series C-2 preferred** offering, though losses persist despite 9,500% revenue growth off low base.
